Mohseninejad, Leyla; Feenstra, Talitha; Horst, Henriëtte; … - In: The European Journal of Health Economics 14 (2013) 6, pp. 947-957
Screening patients with IBS-D or IBS-mix for CD is almost certainly cost-effective. The screening program would improve the quality of life of those patients with IBS symptoms who actually have CD at a relatively low cost. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2013
